GGH and gastric cancer: The elucidation of the mechanism whereby high levels of GGH expression and low levels of FPGS expression could be used as prognostic biomarkers in patients with locally advanced gastric cancer for which the administration of postoperative adjuvant chemotherapy with S-1 is not currently sufficient.